Chemical formula: C₂₃₀₆H₃₅₉₄N₆₁₀O₆₉₄S₂₆ 

Therapeutic indications

Alefacept is indicated for:


Population group: only adults (18 years old or older)

Alefacept is indicated is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Alefacept is contraindicated in the following cases:


at least one of
Human immunodeficiency virus

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.